Cargando…
Immune cells drive new immunomodulatory therapies for myocardial infarction: From basic to clinical translation
The high incidence of heart failure secondary to myocardial infarction (MI) has been difficult to effectively address. MI causes strong aseptic inflammation, and infiltration of different immune cells and changes in the local inflammatory microenvironment play a key regulatory role in ventricular re...
Autores principales: | Nian, Wenjian, Huang, Zijian, Fu, Cong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903069/ https://www.ncbi.nlm.nih.gov/pubmed/36761726 http://dx.doi.org/10.3389/fimmu.2023.1097295 |
Ejemplares similares
-
Immunomodulatory Effects of Cell Therapy after Myocardial Infarction
por: Moore, Joseph B, et al.
Publicado: (2021) -
Regulation of Type 2 Immunity in Myocardial Infarction
por: Xu, Jun-Yan, et al.
Publicado: (2019) -
The role of major immune cells in myocardial infarction
por: Feng, Qiang, et al.
Publicado: (2023) -
Extracellular Matrix Biomaterial Therapy for Myocardial Infarction: New Delivery Route and Immunomodulatory Effects
por: Christman, Karen L.
Publicado: (2023) -
Damage-Associated Molecular Patterns in Myocardial Infarction and Heart Transplantation: The Road to Translational Success
por: Silvis, Max J. M., et al.
Publicado: (2020)